Earnings wrap: Healthways, AmSurg

Wellness venture easily beats estimates, surgery center chain sees supply costs spike
Jul 25, 2012 6:41 AM

Top CCA, AmSurg shareholders sold big in Q2

Both Lazard, Fidelity have cut stakes in half since New Year's
Jul 13, 2012 2:01 PM

The quietest all-time high, like, ever

Shares of AmSurg are up more than 2 percent in mid-day trading and earlier reached $31 for the first time, pushing the company's market cap ever so close to $1 billion. The surgery center operator has now climbed almost 20 percent so far this year — even though it's been very quiet on the corporate news front — and has outpaced the S&P 500 by 12 percent in the past 12 months.

Jul 13, 2012 12:35 PM

AmSurg edges closer to overseas push

SEC filing also details favorable lending terms for outstanding debt
Jul 2, 2012 1:00 PM

Close AmSurg vote for Cigarran

Turns out there are quite a few people who would like to see the end of Tom Cigarran's two-decade involvement with surgery center operator AmSurg.

At AmSurg's annual meeting of shareholders last week, investors overwhelmingly voted in favor of various par-for-the-course proposals as well as the re-election to three-year terms of directors Cynthia Miller and John Popp. Not so with Cigarran, chairman of AmSurg from 1992 to 2009 and its CEO for four years during the '90s. He received just 58.5 percent of the possible votes.

May 23, 2012 7:24 AM

Symbion posts 1Q loss

Year-over-year loss widens for ambulatory surgery center operator
May 15, 2012 11:16 AM

Earnings wrap: Healthways, AmSurg

Wellness manager misses but sees 'greatest visibility since 2008,' surgery center chain beats and raises
Apr 25, 2012 6:51 AM

Proxy wrap: AmSurg, Noranda

Surgery center CFO in line for larger bonus, investors in aluminum maker to vote on new director
Apr 6, 2012 1:24 PM

Veteran Symbion exec to retire

Secretary, chief compliance officer joined surgery center chain in '96; company again reports annual losses of $20M+
Mar 20, 2012 7:11 AM

Analyst: AmSurg going nowhere for now

Cantor Fitzgerald analyst Joe France says investors shouldn't look to AmSurg for price appreciation in the near future. Initiating coverage with a 'hold' rating and a price target of $26, France says "the extent of the market's recovery is unclear" and that CEO Chris Holden and his team have their hands full integrating National Surgical Care. Shares of AmSurg (Ticker: AMSG) closed Monday trading just above $26 and are flat for the year.

Mar 13, 2012 8:41 AM